| JYHZ2500026 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| JYHZ2500025 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| JYHZ2500024 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| JYHZ2500023 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| JYHZ2000109 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2020-05-23 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-10-13 | view |
| JYHZ2000108 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2020-05-16 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-10-13 | view |
| JYHZ2000107 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2020-05-15 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-10-13 | view |
| JYHZ2000106 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2020-05-15 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-10-13 | view |
| JYHS2300020 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-13 | | Dr Reddy's Laboratories Ltd;Kunshan Rotam Reddy Pharmaceutical Co Ltd | | | view |
| JYHS2300019 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(5.2) | Import Drug Application | 2023-02-13 | | Dr Reddy's Laboratories Ltd;Kunshan Rotam Reddy Pharmaceutical Co Ltd | | | view |
| JYHB2400526 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400525 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400524 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400523 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400352 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400351 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400350 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2400349 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2200234 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2022-04-24 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2200233 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2022-04-24 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
